About BrainBits
BrainBits is a Healthcare company based in Springfield (United States) founded in 1999 by Bob Bean, and was acquired by Transnetyx in February 2021. Developer of micro-surgically dissected, live brain tissues from rats and mice for pharmaceutical use. The company was acqui-hired. BrainBits offers products and services including Mouse Tissue, Rat Tissue, Growth Media, Microglia Cells, and Cardiomyocytes. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Animal Models. Its competitors include Biocytogen, Interius Biotherapeutics and Applied StemCell; 3 of its 3 listed competitors have raised funding.
Company details
BrainBits was founded in 1999 in Springfield, United States, focusing on the biotechnology sector for neuroscience research. Live brain structures from embryonic rats and mice are micro-surgically dissected and preserved in nutrient media like Hibernate. Tissue procurement processes are facilitated to enable precise selection from animal cells. Complete cell culturing kits, cardiomyocytes, growth media, and microglia are offered to support pharmaceutical and research applications.
- Headquarters Springfield, United States
- Founders Bob Bean
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website brainbitsllc.com
- Social LinkedIn
- Acquired by Transnetyx (Feb 2021)
- Legal Name Brainbits
- InvestorsTransnetyx
& 1 more
- Acquired by
Products & Services of BrainBits
BrainBits offers a comprehensive portfolio of products and services, including Mouse Tissue, Rat Tissue, Growth Media, Microglia Cells, and Cardiomyocytes.
Fresh tissue from mice for neuroscience studies
Fresh tissue from rats for biological research
Media for cell growth and storage in experiments
Cells for immune and brain research applications
Heart cells for cardiovascular studies
Cryopreservation medium for long-term cell storage
Investors in BrainBits
BrainBits has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Transnetyx and MPG Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on acquiring Midwestern US businesses. | mpgequity.com | Chicago, United States | ||
Automated genotyping services for murine cell lines are developed. | 2000 | transnetyx.com | Memphis, United States |
Investor details for BrainBits
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BrainBits
1 people are tracked at BrainBits (1 in leadership).
| Name | Role | Group |
|---|---|---|
Bob Bean | Co-Founder | Leadership |
Complete people profiles for BrainBits
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BrainBits
3 dated milestones of BrainBits across 22 years, from founding to its latest funding, stage changes and deals.
- Founded BrainBits is founded.
- Exit Acquired by MPG Equity Partners.
- Exit Acquired by Transnetyx.
Competitors of BrainBits
BrainBits has 3 listed competitors in our database, 3 of them funded. They include Biocytogen, Interius Biotherapeutics and Applied StemCell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biocytogen.com | 2008 | Wakefield, United States | $301.11M | 85 | Integrated solutions for next-generation antibody drug development are provided. | |
| interiusbio.com | 2020 | Philadelphia, United States | $129.03M | 25 | Developer of gene therapies for treating multiple diseases | |
| appliedstemcell.com | 2008 | Milpitas, United States | $67.52M | 53 | Provider of animal and cell line models as tools for drug discovery and diagnostics |
Detailed competitors of BrainBits
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as BrainBits (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Brainbits
Complete news archive for BrainBits
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BrainBits
BrainBits was founded in 1999.
BrainBits is headquartered in Springfield, United States.
BrainBits was founded in 1999 in Springfield, United States, focusing on the biotechnology sector for neuroscience research. Live brain structures from embryonic rats and mice are micro-surgically dissected and preserved in nutrient media like Hibernate. Tissue procurement processes are facilitated to enable precise selection from animal cells. Complete cell culturing kits, cardiomyocytes, growth media, and microglia are offered to support pharmaceutical and research applications.
BrainBits's top competitors include Biocytogen, Applied StemCell and Interius Biotherapeutics.
BrainBits offers Mouse Tissue, Rat Tissue, Growth Media, Microglia Cells, and 2 more products and services.
BrainBits has 2 investors. Key investors include Transnetyx, and MPG Equity Partners.
BrainBits operates through Brainbits.
Yes. BrainBits was acquired by Transnetyx in February 2021.